Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds; and the improvement of propagation techniques for growing such biomass on a large scale. The company was incorporated in 2020 and is headquartered in Vancouver, Canada.
KI-Analyse von Nirvana Life Sciences Inc.
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu Nirvana Life Sciences Inc.
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.